Sato, Toshiaki <br/><br/>
Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Jan 2006 
 - 182-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.105.094029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Animals<br/>Anti-Arrhythmia Agents--pharmacology<br/>Bepridil--pharmacology<br/>Cell Line<br/>Cell Separation<br/>Coronary Circulation<br/>Flavoproteins--metabolism<br/>Fluorescence<br/>Guinea Pigs<br/>Heart Diseases--prevention & control<br/>Heart Ventricles--metabolism<br/>Humans<br/>In Vitro Techniques<br/>Kidney--drug effects<br/>Mitochondria--drug effects<br/>Myocytes, Cardiac--drug effects<br/>Potassium Channel Blockers<br/>Potassium Channels--agonists<br/>Sarcolemma--drug effects